1 |
Prior to admission PTA dose |
lamotrigine (800 mg total daily) PTA |
Patient taking more than max daily dose lamotrigine (700 mg total daily) PTA |
|
2 |
Appropriate dose for indication |
Propofol 140 mg given for seizure |
Over set max single dose of 50 mg |
|
3 |
Common off-label use |
Albuterol/Ipratropium inhaler ordered 6 puffs Q4H. |
Exceeds max daily dose of 12 puffs and max single dose of 3 puffs |
This is commonly used off-label in this amount. |
4 |
Approximate weight-based dose |
Dalteparin 17,500 units ordered daily |
Exceeds max calculated weight-based dose (16,−340 units) |
This is an appropriate approximation given practical logistics of dosing (RN would be unable to give this precise amount) |
5 |
Bedside procedure, correct dose documented: |
Triamcinolone 10 mg intradermal ordered for single dose of 10 mg |
Exceeds max single dose. |
Only 1 mg (as recommended for single dose), thus correct dose was documented as being given by MD for procedure. |
6 |
Inappropriate alert (not max dose) |
Magnesium Gluconate 2 g PO ordered one time only. |
Exceeds max single dose (1 g) |
Above set max dose of 1 g but not an unsafe dose. |
Dose - Examples of errors |
|
Example Number |
Error category |
Medication Order |
CDS Rationale |
Clinical Rationale |
|
7 |
Overdose by max dose |
Flurazepam 30–60 mg ordered daily at bedtime prn. |
Max single and max daily dose 30 mg. |
|
8 |
Ordered without indication |
Rifampin 600 mg IV ordered Q12H |
Exceeded max daily dose of 1200 mg. |
However, no apparent indication for patient to be on Rifampin. |
9 |
Order conflicts with admin instructions |
Ibuprofen 600 mg ordered Q4H prn. |
exceeds max daily dose of 3200 mg if given all available doses) |
Automated comments of order stated to not give more than 3200 mg; however, TDD per order is 3600 mg |
10 |
Systems/Order set |
Diltiazem 0.25 mg/kg ordered Q4H prn. |
(daily dose 1.5 mg/kg exceeding max daily dose of 1.05 mg/kg) |
Ordered for arrhythmia per order set but patient without history of, or ongoing, arrhythmia. |
|
Drug-drug Interaction - Examples of non-errors |
|
Example Number |
Error category |
Medication Order |
CDS Rationale |
Clinical Rationale |
|
1 |
Selected quinolones / class Ia & III antiarrhythmics |
Moxifloxacin, Amiodarone Tablet 200 mg |
increased risk for QT prolongation |
benefit > risk for many patients, can be safely monitored. |
2 |
tramadol/MAOIS |
Linezolid, Tramadol Tablet 25 mg |
increased risk for serotonin syndrome |
Requires increased monitoring |
3 |
simvastatin / diltiazem |
simvastatin (> 10 mg); lovastatin (> 20 mg) / diltiazem |
increased risk of statin myopathy |
frequently done in the community if risk for CVD elevated with increased monitoring. |
4 |
anticoagulants / metronidazole; tinidazole |
Warfarin 12.5 mg Tablet, Metronidazole 500 mg |
increased INR |
Can be monitored and dose-adjusted |
5 |
methotrexate / sulfonamides; trimethoprim |
Trimethoprim 160 mg/Sulfamethoxazole 800 mg Tablet 1 tablet, Methotrexate Tablet 10 mg |
methotrexate toxicity |
Patients should be monitored for pancytopenia and myelotoxicity |
6 |
methadone oraloxycodone extended release tablet |
Methadone Tablet 10 mg, Oxycodone SR Tablet 30 mg |
increased CNS depression/ duplicate opiate therapy |
Best practice would be to administer one long acting opiate at a time, but this may be done safely with monitoring in specific clinical settings |
7 |
naltrexone / opioid analgesics |
Naltrexone Tablet 50 mg, Morphine 1–4 mg |
antagonist and agonist co-administered |
frequently done in treatment of acute on chronic pain |
Drug-drug Interaction - Examples of errors |
|
Example Number |
Error category |
Medication Order |
CDS Rationale |
Clinical Rationale |
|
8a |
heparin subq / enoxaparin |
Enoxaparin 120 mg, Heparin 5000 Units |
duplicate anticoagulant |
increased risk of bleeding with low likelihood of clinical benefit |
8b |
heparins-dabigatran |
Dabigatran Capsule 150 mg, Heparin 5000 Units |
duplicate anticoagulant |
increased risk of bleeding with low likelihood of clinical benefit |
9a |
cgmp specific pde type-5 inhibitors / nitrates |
Sildenafil Tablet 12.5 mg, Nitroglycerin Sublingual Tablet 0.4 mg |
hypotension, duplicate class |
SL NTG and PDE’s are OK if both are PRN and pt. is educated, but Long acting/ standing nitrates are not OK |
|
|
|
|
with PDE’s: isosorbide mononitrate, transdermal patches, isosorbide mononitrate |
9b |
gentamicin / tobramycin |
Gentamicin, Tobramycin |
duplicate class |
increased risk of toxicity. Duplicate class |